Assisted Reproductive Technology Market Forecast to Grow at 19.4% CAGR from 2023 to 2032

The global assisted reproductive technology (ART) market was valued at USD 31.85 billion in 2022 and is projected to reach USD 179.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 19.4%. This substantial growth can be attributed to several factors, including rising infertility rates, advancements in medical technologies, and increased societal acceptance of ART procedures. Key drivers include the rising incidence of infertility due to lifestyle changes, such as delayed parenthood and increased obesity. Technological advancements, such as in-vitro fertilization (IVF) and pre-implantation genetic testing (PGT), have significantly improved success rates and patient outcomes.

However, the market faces several challenges. High treatment costs and ethical concerns surrounding ART procedures are significant barriers, particularly in developing regions where affordability remains a critical issue. Moreover, stringent regulatory frameworks and the socio-cultural stigma associated with infertility treatments further hinder market growth.

Recent developments in the field include the launch of advanced cryopreservation solutions and the integration of telemedicine for remote patient monitoring. For instance, in June 2022, Inception Fertility introduced HavenCryo, enhancing long-term reproductive tissue storage. Additionally, collaborations and acquisitions, such as Hamilton Thorne Ltd.’s acquisition of IVFtech, are expanding the technological capabilities within the market.

Regionally, Europe dominates the ART market due to a high prevalence of infertility and supportive government policies, while the Asia-Pacific region is expected to witness the fastest growth, driven by increasing infertility rates and rising awareness of ART treatments.

Key Takeaways

• The global assisted reproductive technology (ART) market is experiencing a CAGR of 19.4% from 2023 to 2032.
• In 2022, accessory and disposable-type ART products held the largest market share, accounting for 52.3%.
• In-vitro fertilization (IVF) led the technology segment with an 87% market share in 2022.
• Fresh non-donor procedures were the most lucrative, representing 40% of the market in 2022.
• Fertility clinics dominated as end-users, contributing 40.5% to the market in 2022.
• Technological advancements like IVF and ICSI have significantly improved the success rates of ART.
• Rising disposable incomes are making assisted reproductive technology more accessible to a broader population.
• Increased awareness and government support are driving the growing demand for ART services.
• Europe emerged as the most lucrative market, holding a 39.2% market share.
• The Asia Pacific region is showing rapid growth due to increasing awareness and demand for ART.

Get Sample PDF Report: https://market.us/report/assisted-reproductive-technology-market/request-sample/

Assisted Reproductive Technology Market Key Segments

Based on Type

• Instrument
• Sperm Separation System
• Cryosystem
• Incubator
• Imaging System
• Ovum Aspiration Pump
• Cabinet
• Micromanipulator
• Laser Systems
• Others
• Accessory & Disposable
• Reagents & Media
• Cryopreservation Media
• Semen Processing Media
• Ovum Processing Media
• Embryo Culture Media

Based on Technology

• In Vitro-Fertilization
• Artificial Insemination
• Frozen Embryo Transfer
• Other Technologies

Based on Procedure

• Fresh Donor
• Fresh Non-donor
• Frozen Donor
• Frozen Non-donor

Based on End-User

• Fertility Clinic
• Hospital
• Surgical Center
• Clinical Research Institute
• Other End-Users

Key Regions

• North America (The US, Canada, Mexico)
• Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
• Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
• APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
• Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
• Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=63178

Key Players Analysis

• Cosmos Biomedical Ltd. operates within the Assisted Reproductive Technology (ART) sector, offering innovative solutions for fertility treatments. The company focuses on advanced medical devices and technologies that support in-vitro fertilization (IVF) procedures. Cosmos Biomedical’s contributions include the development and distribution of high-quality laboratory equipment and consumables crucial for successful ART outcomes. Their products are designed to enhance the efficiency and effectiveness of fertility clinics worldwide, helping to improve pregnancy success rates and patient care.
• Microm U.K. Ltd. is a key player in the ART market, providing specialized equipment and solutions for reproductive health. The company is known for its precision instruments used in IVF laboratories, such as micro-manipulators and advanced imaging systems. These tools are essential for procedures like egg retrieval and embryo transfer, ensuring high accuracy and safety. Microm U.K. Ltd.’s commitment to quality and innovation makes it a trusted partner for fertility clinics and research institutions globally.
• CooperSurgical Inc. is a prominent name in the ART industry, offering a wide range of products and services designed to improve reproductive health. Their portfolio includes fertility preservation solutions, IVF laboratory products, and genetic testing services. CooperSurgical’s recent acquisition of Generate Life Sciences has expanded its capabilities in donor egg and sperm services, further strengthening its position in the market. The company’s focus on cutting-edge technology and patient-centered care drives its success in the ART sector.
• FUJIFILM Irvine Scientific is a leading provider of cell culture media and related products for ART. Their offerings include media for embryo culture, sperm processing, and cryopreservation, which are critical components in IVF procedures. The company’s products are known for their consistency and reliability, supporting successful fertilization and embryo development. FUJIFILM Irvine Scientific’s commitment to research and development ensures that their solutions meet the evolving needs of the ART market.
• Cryolab Ltd. specializes in cryopreservation services within the ART field. They provide storage solutions for reproductive cells, including sperm, eggs, and embryos, which are vital for fertility treatments and long-term reproductive planning. Cryolab Ltd.’s facilities and strict quality control measures ensure the highest standards of preservation. Their services offer patients and clinics reliable options for preserving reproductive material, contributing to the overall success of ART procedures.

Assisted Reproductive Technology Market Key Players:

• Cosmos Biomedical Ltd.
• Microm U.K. Ltd.
• CooperSurgical Inc.
• FUJIFILM Irvine Scientific
• Cryolab Ltd.
• Vitrolife AB
• European Sperm Bank
• Bloom IVF Centre
• Merck KGaA
• Ferring B.V.
• Cook Medical Inc.
• Fujifilm Holdings Corporation
• Genea Biomedx
• Thermo Fisher Scientific Inc.
• Millendo Therapeutics Inc.
• Oxford Gene Technology
• Progyny Inc.
• Other Key Players

Assisted Reproductive Technology Market Report Scope >> Market Value (2023): USD 31.9 Billion || Forecast Revenue (2033): USD 179.4 Billion || CAGR (2024-2033): 19.4% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.

Inquire More about report: https://market.us/report/assisted-reproductive-technology-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.

Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/

View More Trending Reports

Medical 3D Printing Market Projected to reach USD 4593.7 Mn with 19.5% CAGR By 2033

Medical Camera Market Estimated to Reach USD 6.4 Billion by 2033

Cimzia (certolizumab) Drug Market Poised to Reach USD 7.3 Billion by 2033

Veterinary Surgical Instruments Market Expected to Attain USD 2.2 Billion by 2033

Glucagon Market Sees Surge, Reaches USD 1102.2 Mn Value by 2033